Filtered By:
Condition: Ischemic Stroke
Procedure: PET Scan
This page shows you your search results in order of date. This is page number 8.
Order by Relevance | Date
Total 2299 results found since Jan 2013.
A novel method for preparing clot analogs under dynamic vortical flow for testing mechanical thrombectomy devices
CONCLUSIONS: Dynamic clots generated in dynamic vortical flow differ significantly from static clots in terms of their composition and mechanical properties, which may be beneficial information for preclinical research on mechanical thrombectomy devices.PMID:37309134 | DOI:10.1177/15910199231182850
Source: Interventional Neuroradiology - June 13, 2023 Category: Radiology Authors: Ronghui Liu Bin Lv Haoye Meng Luo Zhang Weijing Ma Hongping He Ren Wei Na Ma Yubo Fan Jun Wang Xuewen Ren Weidong Wang Source Type: research
Impact of the first response unit on prehospital on-scene time among paramedic-suspected stroke patients: a retrospective before –after cohort study in Finland
Revascularization of an occluded artery by either thrombolysis or mechanical thrombectomy is a time-critical intervention in ischaemic stroke. Each link in the stroke chain of survival should minimize the dela...
Source: Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine - June 13, 2023 Category: Emergency Medicine Authors: Verna K.E. Vaajanen, Pauli E.T. Vuorinen, Piritta A. Set älä, Reija Autio and Sanna E. Hoppu Tags: Original research Source Type: research
Predicting models for arm impairment: External validation of the Scandinavian models and identification of new predictors in post-acute stroke settings
CONCLUSION: Scandinavian item-level predictors are valid in a different context, finger mass flexion outperformed known predictors, days-to-admission predict discharge mild arm impairment.PMID:37248917 | DOI:10.3233/NRE-220233
Source: NeuroRehabilitation - May 30, 2023 Category: Rehabilitation Authors: Alejandro Garc ía-Rudolph Ignasi Soriano Helard Becerra Vince Istvan Madai Dietmar Frey Eloy Opisso Josep Mar ía Tormos Montserrat Bernabeu Source Type: research
Optimization of collateral grading on computer tomography angiography
CONCLUSION: A dual-phase CTA is significantly similar to a mCTA assessment of collateral score and may be applied at community-based centers. Absolute or relative thresholds for torcula opacification may be used to identify poor bolus-scan timing thus preventing erroneous assumptions of poor collaterals on sCTA.PMID:37226428 | DOI:10.1177/15910199231176310
Source: Interventional Neuroradiology - May 25, 2023 Category: Radiology Authors: Leonardo Pisani Diogo C Haussen Mahmoud Mohammaden Catarina Perry da Camara Gabriel M Rodrigues Mehdi Bouslama Alhamza Al-Bayati Ranliang Hu Nicholas Bianchi Nirav Ravindra Bhatt Michael Frankel Raul G Nogueira Source Type: research
Scalp acupuncture regulates functional connectivity of cerebral hemispheres in patients with hemiplegia after stroke
ConclusionThe changes in functional connectivity between the cerebral cortex and basal ganglia in patients with cerebral infarction showed a weakening of the bilateral hemispheres and the enhancement of the connections between the hemispheres. Scalp acupuncture has the function of bidirectional regulation, which makes the unbalanced abnormal brain function state restore balance.
Source: Frontiers in Neurology - May 25, 2023 Category: Neurology Source Type: research
Altered dynamic functional network connectivity states in patients with acute basal ganglia ischemic stroke
CONCLUSIONS: AIS not only altered the interaction between the different dynamic networks but also promoted characteristic alterations in the temporal and topological features of large-scale dynamic network connectivity.PMID:37201623 | DOI:10.1016/j.brainres.2023.148406
Source: Brain Research - May 18, 2023 Category: Neurology Authors: Zhongming Li Zhimin Wang Dairong Cao Ruixiong You Jianping Hu Source Type: research
Roche ’s BTK inhibitor fenebrutinib significantly reduced brain lesions in people with relapsing forms of multiple sclerosis
Fenebrutinib is an investigational, potent and highly selective oralBruton ’s tyrosine kinase (BTK) inhibitor, the only reversible BTK inhibitor currently in Phase III multiple sclerosis (MS) trialsPhase II study met its primary and secondary endpoints by reducing the total number of new gadolinium-enhancing T1 brain lesions and significantly reducing the total number of new or enlarging T2 brain lesions compared to placeboThe safety profile offenebrutinib was consistent with previous and ongoing clinical trials across more than 2,400 people to dateBasel, 17 May 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today p...
Source: Roche Media News - May 17, 2023 Category: Pharmaceuticals Source Type: news
